Medicines List

Select category
  • Description

    Coolsart is a combination of an angiotensin II receptor antagonist with olmesartan medoxomil and a thiazide diuretic – hydrochlorothiazide. The combination of these ingredients has an additive antihypertensive effect which reduces blood pressure to a greater degree than either component alone.

    Indications

    Coolsart 20 mg/12.5 mg film-coated tablets
    – treatment of essential hypertension;
    – olmesartan medoxomil/hydrochlorothiazide 20 mg/12.5 mg fixed-dose combination is indicated in adult patients whose blood pressure is not adequately controlled on olmesartan medoxomil alone.

    Coolsart 40 mg/12.5 mg film-coated tablets
    – treatment of essential hypertension;
    – olmesartan/hydrochlorothiazide 40 mg/12.5 mg fixed-dose combinations is indicated in adult patients whose blood pressure is not adequately controlled on olmesartan medoxomil 40 mg alone.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 20 mg/12.5 mg; 40 mg/12.5 mg film-coated tablets

    Patient information leaflet

  • Description

    Bilamcar combines two antihypertensive compounds with complementary mechanisms to control blood pressure in patients with essential hypertension: an angiotensin II receptor antagonist, candesartan cilexetil and a dihydropyridinic calcium channel blocker, amlodipine. The combination of these substances has an additive antihypertensive effect, reducing blood pressure to a greater degree than either component alone.

    Indications

    Bilamcar is indicated for treatment of essential hypertension as substitution therapy in adult patients whose blood pressure is already adequately controlled with the individual components given concurrently at the same dose levels as in the fixed combination, but as separate medicines.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 8 mg/5 mg, 8 mg/10 mg, 16 mg/5 mg, 16 mg/10 mg hard capsules

    Patient information leaflet

  • Description

    Pizona Combi contains pioglitazone and metformin.
    Pizona Combi helps control the level of sugar in your blood when you have type 2 diabetes by helping your body make better use of the insulin it produces.

    Indications

    Pizona Combi is indicated as second line treatment of type 2 diabetes mellitus in adult patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 15 mg/ 850 mg film-coated tablets

    Patient information leaflet

  • Description

    Aroba belongs to a class of medicines for treatment of diabet (alpha glucosidase inhibitors). The active substance in Aroba is acarbose and has a biological origin.
    Aroba slows down the breakdown of carbohydrates, which slows down the release of glucose and its passage into the blood. In this way, Aroba slows down and reduces the rise in blood sugar after eating.

    Indications

    – Additional treatment, together with diet, in patients with diabetes mellitus.
    – Prevention of type 2 diabetes in patients with proven impaired glucose tolerance, in combination with diet and exercise.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 100 mg tablets

    Patient information leaflet